Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Severe Hyperglycemia and Ketonuria Management

Assessment and Risk Stratification

  • The American Diabetes Association recommends that patients with severely elevated blood glucose and ketonuria should be sent to the emergency department immediately, due to the high risk of diabetic ketoacidosis and other acute complications, even if asymptomatic 1, 2.
  • The presence of ketonuria in the setting of severe hyperglycemia is highly concerning for evolving diabetic ketoacidosis (DKA), which is a medical emergency requiring prompt treatment 2.
  • The absence of symptoms does not rule out serious underlying metabolic abnormalities; patients can have significant ketosis and acidosis with minimal or no symptoms initially 3.
  • Blood glucose values >250-500 mg/dL with ketonuria represent Grade 3-4 severity that requires immediate medical intervention, according to diabetes management guidelines 1.
  • The presence of proteinuria along with ketonuria and glucosuria suggests possible end-organ damage, which further necessitates urgent evaluation 4, 3.

Potential Complications and Management

  • Without prompt treatment, patients with severe hyperglycemia and ketonuria are at risk for progression to full diabetic ketoacidosis, electrolyte abnormalities, volume depletion, and mental status changes that may develop rapidly 2, 3.
  • Initial management of severe hyperglycemia with ketonuria requires intravenous fluid resuscitation, insulin therapy, electrolyte monitoring and replacement, and close monitoring of vital signs and mental status 2, 3.
  • The American College of Emergency Physicians recommends that these interventions are best provided in an emergency department setting where laboratory monitoring and rapid intervention are available 1, 2.
  • Attempting outpatient management of a patient with this degree of metabolic derangement is not recommended and may lead to delayed treatment of potentially life-threatening complications 1.